We wish to comment on reference intervals for the serum anion gap and osmolality. The serum anion gap, which is most commonly defined as AG ϭ Na-Cl-TCO 2 , traditionally has had a reference interval of 8 -16 mmol/L with a mean value (i.e., mean of values used to determine its reference interval) of 12 mmol/L (1, 2). In a recent report (3), the stated reference interval for the anion gap was 12-16 mmol/L with potassium included in the calculation, approximately equivalent to 8 -12 mmol/L without inclusion of potassium. This range of only 4 mmol/L appears to be too narrow for a healthy human population. Moreover, recent studies have shown that mean values for current analyzers often differ from the traditional value and may vary from 5.9 mmol/L for the Beckman Synchron to 12.4 mmol/L for the Nova analyzer (4 -6). Consequently, depending on the analyzer used, the serum anion gap reference interval may be as low as 2-10 mmol/L or as high as the traditional range of 8 -16 mmol/L. We have also found marked interlaboratory differences in measurements by the same type of analyzer (6). Thus, interpretation of the anion gap requires that each clinical laboratory determine its own reference interval.
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The reference interval for serum osmolality also deserves study. One recent report (3) included a reference interval of 270 -290 mOsm/kg. We believe this interval is inappropriately low, based on our duplicate measurements of serum osmolality by freezing point depression (Advanced Instruments Model 3MO osmometer) in 59 healthy volunteers of ages 20 -60 years. Kolmogorov-Smirnov analysis indicated that we could not reject the hypothesis that the results were normally distributed (P ϭ 0.64). The mean serum osmolality was 288 mOsm/kg, with a SD of 4.1 mOsm/kg, yielding a parametric reference interval of 280 -298 mOsm/kg. The lowest and highest values measured were 280 and 298 mOsm/kg, respectively. Other published serum osmolality reference intervals based on freezing point depression measurements are 275-290 or 275-295 mOsm/kg in children and adults and 280 -301 mOsm/kg in adults Ͼ60 years of age (7, 8 
Capillary Electrophoresis in the Analysis of the Deletion/Insertion Polymorphism of the Angiotensin I-Converting Enzyme Gene
Capillary gel electrophoresis (CGE) in molecular pathology and genetics is an ideal instrument for fast, fully automated analysis. The number of reports dealing with the analysis of, e.g., PCR products, is continuously increasing. In this context, we noticed with interest the description of a CGE analysis of the angiotensin I-converting enzyme polymorphism by X.H. Huang et al. (1) . The CGE procedure is very similar to our communication published in 1996 (2), but with our method, running times are substantially shorter: we have separation times of Ͻ10 min (2). In general, modern CGE analysis of PCR products can easily be achieved in Ͻ10 min when there are such big differences in basepairs (100 -300 bp) (3, 4) .
If Huang et al.
(1) plan to screen a large number of samples for the angiotensin I-converting enzyme polymorphism by CGE, the use of a polyacrylamide-coated capillary and 0.6% hydroxyethylcellulose will increase their sample throughput by nearly 300%. 
Rainer Lehmann
Acute Effects of Fracture on Bone Markers and Vitamin K
To the Editor: New biochemical markers provide useful information in the diagnosis and monitoring of metabolic bone disease and in the prediction of fracture risk. Vitamin K has become increasingly of interest in this field because of its role as a cofactor in the carboxylation of osteocalcin (1). Because hip fractures generally occur in severely osteoporotic patients, biochemical markers of bone metabolism and vitamin K have been studied extensively in patients with hip fractures. However, it is not clear whether a fracture itself affects the concentrations of biochemical markers of bone metabolism or, if so, how soon after or for how long after the fractures. The ideal way to study this is to obtain samples before a fracture. This is not feasible, however, because it requires a huge amount of sampling and a long follow-up. A secondary way is to do successive sampling immediately after a fracture to observe whether values change.
We studied 28 women with hip fracture, ages 64 -94 years (mean age, 80.3 years). Their fractures were caused by low-energy trauma, such as a fall. They were immediately taken to an emergency room at a hospital. Serum and urine were collected from them on 3 successive days immediately after admission to the hospital (termed day 0). Most patients had surgery on day 2 after the sampling of that day. All had been ambulatory before the fracture. Exclusion criteria were: hip fractures resulting from severe trauma, admission to the hospital Ͼ24 h after the onset of fracture, blood transfusions or surgical procedures during the period of sample collection, past and present illnesses related to bone metabolism, and increased concentrations of serum creatinine. No subjects had been treated for osteoporosis, and none received medications before or during the study that might have affected calcium metabolism. Informed consent was obtained from all participants. The procedures followed were in accordance with the principles of the Declaration of Helsinki in 1975, as revised in 1983.
Serum osteocalcin was measured by RIA with a Yamasa osteocalcin kit with the use of polyclonal antibodies. Intra-and interassay CVs were Ͻ15%. Pyridinoline and deoxypyridinoline in urine were measured by HPLC after hydrolysis according to an automated analysis described by Pratt et al. (2) . Before hydrolysis, urinary creatinine content was measured. The values of urinary Pyr and Dpyr were expressed per mol of urinary creatinine. The intra-and interassay CVs were Ͻ10%. Vitamin K 1 , menaquinone 4 (MK4), and menaquinone 7 (MK7) were measured by HPLC. The method is based on a hydrogen gas-saturated mobile phase with fluorescent detection after postcolumn reduction by a platinum oxide catalyst column (3) . The detection limits with 1 mL of plasma were 0.1 g/L for vitamin K 1 , MK-4, and MK-7. The CVs were Ͻ5%. Urinary ␥-carboxyglutamic acid was measured by HPLC. An aliquot of the urine was chromatographed on an anion-exchange column with a silica-based microparticulate support, and the amino acids of the eluate were detected fluorometrically by postcolumn derivatization with ophthalaldehyde (4). The CV was 6.3%. The statistical significance of differences was determined with nonparametric statistics using a Wilcoxon signed-rank test. P values of Ͻ0.05 were considered significant.
Alkaline phosphatase and osteocalcin did not change significantly during the 3 days (Table 1 ). Pyr and Dpyr slightly but significantly increased on the third day (P Ͻ0.05). Vitamin K 1 and MK7 showed a 20 -30% reduction, but this was not significant. Because MK4 was detected in only one patient, the data are not shown. Although the reduction of urinary ␥-carboxyglutamic acid was slight, its decrease on the third day was significant (P Ͻ0.05). Thus biochemical markers of bone turnover were not affected for at least 48 h after fracture.
Most previous publications on longitudinal changes of biochemical markers of bone turnover after fractures have focused on the changes over a period of months. Few reports have looked for acute changes after fracture. Although a report of osteocalcin measurements within 22 h of hip fracture (5) described a slight but significant correlation between osteocalcin and the time after fracture, the study was cross-sectional. This is the first report to investigate acute successive changes of vitamin K and biochemical markers of bone turnover in patients with hip fractures. Because proteins that require vitamin K were involved in blood coagulation, it was expected that vitamin K would be consumed in the process of a large fracture such as in the hip. However, the results in this Clinical Chemistry 44, No. 7, 1998 
